Skip to main content

In silico modeling predicts drug sensitivity of patient-derived cancer cells

Glioblastoma (GBM) is an aggressive disease associated with poor survival.

Journal of Translational Medicine 2014 Glioblastoma Multiforme
READ MORE

STAY INFORMED

Top